Latest Healthcare It News

Page 1 of 178
Mesoblast Limited reports a 60% jump in Ryoncil sales for the December quarter, underpinned by a new $125 million financing facility that strengthens its balance sheet and strategic flexibility.
Ada Torres
Ada Torres
9 Jan 2026
InhaleRx Limited has completed the final tranche of its share placement, raising $600,000 to support its clinical-stage drug development programs targeting pain and mental health.
Ada Torres
Ada Torres
9 Jan 2026
Nyrada has secured ethics approval to begin a pivotal Phase IIa trial of its drug Xolatryp, targeting heart attack damage. Patient dosing is set to start in March 2026 across multiple Australian hospitals.
Ada Torres
Ada Torres
8 Jan 2026
Imagion Biosystems has completed the conversion of its first tranche convertible notes with Mercer Street, issuing over 3 million shares, while renegotiating terms on the second tranche to extend maturity and reduce debt.
Ada Torres
Ada Torres
8 Jan 2026
Alcidion has been named the preferred supplier for University Hospitals Sussex's new Electronic Patient Record system, with a contract expected to exceed A$35 million over seven years. This deal builds on an existing partnership and marks a significant expansion for Alcidion in the UK healthcare IT market.
Ada Torres
Ada Torres
8 Jan 2026
Hydrix Limited’s subsidiary has landed a significant A$2.5 million contract to develop SynCardia’s next-generation fully implantable Total Artificial Heart, marking a major step in advanced cardiovascular technology.
Ada Torres
Ada Torres
7 Jan 2026
Neuren Pharmaceuticals has published promising Phase 2 trial results for NNZ-2591 in Phelan-McDermid syndrome, underpinning its ongoing Phase 3 Koala trial recruiting in the US.
Ada Torres
Ada Torres
7 Jan 2026
CurveBeam AI has received official Chinese regulatory approval for a strategic $10 million investment from WEGO Orthopaedics, marking a major step in its expansion into Greater China. The initial $4 million tranche at a premium share price is expected imminently, underpinning a decade-long commercialisation deal.
Ada Torres
Ada Torres
7 Jan 2026
UC San Diego Health has begun clinical use of 4DMedical’s CT – VQ™, marking the fourth leading US academic medical centre to adopt this innovative lung imaging technology since FDA clearance. This milestone underscores 4DMedical’s rapid commercial traction and growing influence in respiratory diagnostics.
Ada Torres
Ada Torres
7 Jan 2026
Orthocell has reported a record $3.2 million in quarterly revenue, marking its seventh consecutive quarter of growth, driven by strong sales of its Remplir™ nerve repair product in Australia and early traction in the US market.
Ada Torres
Ada Torres
6 Jan 2026
Nexsen Limited has initiated FDA engagement for its rapid Group B Streptococcus diagnostic sensor, aiming for expedited US market entry, while bolstering its leadership team and scientific credentials.
Ada Torres
Ada Torres
6 Jan 2026
BlinkLab Limited has secured independent scientific validation for its smartphone-based autism diagnostic technology through publication in the prestigious journal Autism Research, marking a significant milestone ahead of its FDA regulatory trial.
Ada Torres
Ada Torres
5 Jan 2026